Trump set to impose new tariffs on certain pharmaceutical drugs

Key Points:

• President Donald Trump plans to impose new tariffs on pharmaceutical companies that have not agreed to sell their drugs directly to consumers under his "Most Favored Nation" pricing initiative, targeting imports of patented drugs and their active ingredients with a proposed 100% tariff.
• The draft order allows drugmakers to reduce or avoid these tariffs by negotiating deals with the administration or relocating production to the United States, with a possible reduced tariff of 20% for four years before reverting to 100% in 2030.
• This move aims to revive Trump's aggressive trade strategy following a Supreme Court ruling that struck down some of his previous tariffs as unconstitutional, despite concerns that such levies could increase drug prices for Americans.
• The "Most Favored Nation" initiative currently covers a limited number of drugs, many with cheaper generic alternatives, and the new tariffs are intended to encourage more companies to participate in the program.
• The draft order is not final and may change, with the tariffs expected to be announced soon, while the White House has yet to comment on the proposal.